Involuntary euthanasia of severely ill newborns: is the Groningen Protocol really dangerous?

被引:0
|
作者
Voultsos, P.
Chatzinikolaou, F.
机构
关键词
Active euthanasia; newborn; neonatal; Groningen Protocol; bioethics; virtue ethics; principlism; beneficence; withholding; withdrawing; OF-LIFE DECISIONS; INTENSIVE-CARE UNITS; ETHICAL CONSIDERATIONS; GESTATIONAL-AGE; END; INFANTS; MEDICINE; ABORTION; CHILDREN; BIRTH;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Advances in medicine can reduce active euthanasia of newborns with severe anomalies or unusual prematurity, but they cannot eliminate it. In the Netherlands, voluntary active euthanasia among adults and adolescents has been allowed since 2002, when the so-called Groningen Protocol (GP) was formulated as an extension of the law on extremely premature and severely ill newborns. It is maintained that, at bioethical level, it serves the principle of beneficence. Other European countries do not accept the GP, including Belgium. Admissibility of active euthanasia is a necessary, though inadequate, condition for acceptance of the GP. Greece generally prohibits euthanasia, although the legal doctrine considers some of the forms of euthanasia permissible, but not active or involuntary euthanasia. The wide acceptance of passive newborns euthanasia, especially when the gestational age of the newborns is 22-25 weeks ("grey zone"), admissibility of practices within the limits between active and passive euthanasia (e. g., withholding/withdrawing), of "indirect active euthanasia" and abortion of the late fetus, the tendency to accept after-birth-abortion (infanticide) in the bioethical theory, the lower threshold for application of withdrawing in neonatal intensive care units compared with pediatric intensive care units, all the above advocate wider acceptance of the GP. However, the GP paves the way for a wide application of involuntary (or pseudo-voluntary) euthanasia (slippery slope) and contains some ambiguous concepts and requirements (e. g., "unbearable suffering"). It is suggested that the approach to the sensitive and controversial ethical dilemmas concerning the severely ill newborns is done not through the GP, but rather, through a combination of virtue bioethics (especially in the countries of the so-called "Mediterranean bioethical zone") and of the principles of principlism which is enriched, however, with the " principle of mutuality" (enhancement of all values and principles, especially with the principles of " beneficence" and " justice"), in order to achieve the "maximal" bioethical approach, along with the establishment of circumstances and alternatives that minimize or eliminate the relevant bioethical dilemmas and conflicts between the fundamental principles. Thus, the most appropriate/fairest choices are made (by trained parents and physicians), considering all interests involved as much as possible.
引用
收藏
页码:196 / 203
页数:8
相关论文
共 39 条
  • [31] What contributes to good patient outcomes in the home treatment of the severely mentally ill: study protocol of a multi-centre analysis
    Constance Stegbauer
    Katja Goetz
    Erik Bauer
    Beate Bestmann
    Thomas Ruprecht
    Joachim Szecsenyi
    Anke Bramesfeld
    BMC Psychiatry, 13
  • [32] Tri-Response Police, Ambulance, Mental Health Crisis Models in Reducing Involuntary Detentions of Mentally Ill People: Protocol for a Systematic Review
    Heffernan, Julia
    McDonald, Ewan
    Hughes, Elizabeth
    Gray, Richard
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (15)
  • [33] National strategy for palliative care of severely ill and dying people and their relatives in pandemics (PallPan) in Germany - study protocol of a mixed-methods project
    C. Bausewein
    F. Hodiamont
    N. Berges
    A. Ullrich
    C. Gerlach
    K. Oechsle
    B. Pauli
    J. Weber
    S. Stiel
    N. Schneider
    N. Krumm
    R. Rolke
    C. Gebel
    M. Jansky
    F. Nauck
    U. Wedding
    B. van Oorschot
    C. Roch
    L. Werner
    M. Fischer
    M. Schallenburger
    M. C. Reuters
    J. Schwartz
    M. Neukirchen
    A. Gülay
    K. Maus
    B. Jaspers
    L. Radbruch
    M. Heckel
    I. Klinger
    C. Ostgathe
    U. Kriesen
    C. Junghanß
    E. Lehmann
    D. Gesell
    S. Gauder
    C. Boehlke
    G. Becker
    A. Pralong
    J. Strupp
    C. Leisse
    K. Schloesser
    R. Voltz
    N. Jung
    S. T. Simon
    BMC Palliative Care, 21
  • [34] National strategy for palliative care of severely ill and dying people and their relatives in pandemics (PallPan) in Germany-study protocol of a mixed-methods project
    Bausewein, C.
    Hodiamont, F.
    Berges, N.
    Ullrich, A.
    Gerlach, C.
    Oechsle, K.
    Pauli, B.
    Weber, J.
    Stiel, S.
    Schneider, N.
    Krumm, N.
    Rolke, R.
    Gebel, C.
    Jansky, M.
    Nauck, F.
    Wedding, U.
    van Oorschot, B.
    Roch, C.
    Werner, L.
    Fischer, M.
    Schallenburger, M.
    Reuters, M. C.
    Schwartz, J.
    Neukirchen, M.
    Guelay, A.
    Maus, K.
    Jaspers, B.
    Radbruch, L.
    Heckel, M.
    Klinger, I.
    Ostgathe, C.
    Kriesen, U.
    Junghanss, C.
    Lehmann, E.
    Gesell, D.
    Gauder, S.
    Boehlke, C.
    Becker, G.
    Pralong, A.
    Strupp, J.
    Leisse, C.
    Schloesser, K.
    Voltz, R.
    Jung, N.
    Simon, S. T.
    BMC PALLIATIVE CARE, 2022, 21 (01)
  • [35] DECREASED CD4+CD25HIGHFOXP3+CD127LOW T REGULATORY CELL LEVELS IN ASSOCIATION WITH LYMPHOPENIA PREDICT POOR OUTCOME IN SEVERELY ILL NEWBORNS
    Pankratyeva, L.
    Mukhin, V.
    Degtyareva, M.
    Bykovskaia, S.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 52 - 52
  • [36] Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial
    Maes, Bastiaan
    Bosteels, Cedric
    De Leeuw, Elisabeth
    Declercq, Jozefien
    Van Damme, Karel
    Delporte, Anja
    Demeyere, Benedicte
    Vermeersch, Stefanie
    Vuylsteke, Marnik
    Willaert, Joren
    Bolle, Laura
    Vanbiervliet, Yuri
    Decuypere, Jana
    Libeer, Frederick
    Vandecasteele, Stefaan
    Peene, Isabelle
    Lambrecht, Bart
    TRIALS, 2020, 21 (01)
  • [37] Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial
    Bastiaan Maes
    Cedric Bosteels
    Elisabeth De Leeuw
    Jozefien Declercq
    Karel Van Damme
    Anja Delporte
    Bénédicte Demeyere
    Stéfanie Vermeersch
    Marnik Vuylsteke
    Joren Willaert
    Laura Bollé
    Yuri Vanbiervliet
    Jana Decuypere
    Frederick Libeer
    Stefaan Vandecasteele
    Isabelle Peene
    Bart N. Lambrecht
    Trials, 21
  • [38] Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial
    Eckhardt, Christina M.
    Cummings, Matthew J.
    Rajagopalan, Kartik N.
    Borden, Sarah
    Bitan, Zachary C.
    Wolf, Allison
    Kantor, Alex
    Briese, Thomas
    Meyer, Benjamin J.
    Jacobson, Samuel D.
    Scotto, Dawn
    Mishra, Nischay
    Philip, Neena M.
    Stotler, Brie A.
    Schwartz, Joseph
    Shaz, Beth
    Spitalnik, Steven L.
    Eisenberg, Andrew
    Hod, Eldad A.
    Justman, Jessica
    Cheung, Ken
    Lipkin, W. Ian
    O'Donnell, Max R.
    TRIALS, 2020, 21 (01)
  • [39] Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial
    Christina M. Eckhardt
    Matthew J. Cummings
    Kartik N. Rajagopalan
    Sarah Borden
    Zachary C. Bitan
    Allison Wolf
    Alex Kantor
    Thomas Briese
    Benjamin J. Meyer
    Samuel D. Jacobson
    Dawn Scotto
    Nischay Mishra
    Neena M. Philip
    Brie A. Stotler
    Joseph Schwartz
    Beth Shaz
    Steven L. Spitalnik
    Andrew Eisenberger
    Eldad A. Hod
    Jessica Justman
    Ken Cheung
    W. Ian Lipkin
    Max R. O’Donnell
    Trials, 21